WordNet

a special situation; "this thing has got to end"; "it is a remarkable thing"
a separate and self-contained entity
an action; "how could you do such a thing?"
an artifact; "how does this thing work?"
an entity that is not named specifically; "I couldnt tell what the thing was"
any attribute or quality considered as having its own existence; "the thing I like about her is ..."
a persistent illogical feeling of desire or aversion; "he has a thing about seafood"; "she has a thing about him"
a special abstraction; "a thing of the spirit"; "things of the heart"
a special objective; "the thing is to stay in bounds"
a statement regarded as an object; "to say the same thing in other terms"; "how can you say such a thing?"
an event; "a funny thing happened on the way to the..."
any of various organs that synthesize substances needed by the body and release it through ducts or directly into the bloodstream (同)secretory organ, secretor, secreter
an abnormal new mass of tissue that serves no purpose (同)tumour, neoplasm

PrepTutorEJDIC

〈C〉(形のある)『物』,物体;(生物に対しての)『無生物』 / 〈C〉(形のない)『もの』,事,事柄,でき事 / 《複数形で》事情,事態,状勢,状況 / 《複数形で》(すべての)事物,事柄 / 《通例 the~》(努力・活動などの)目的,目標 / 〈C〉衣服,衣類・《one's things》持ち物,所持品,身の回り品 / 《複数形で》道具,用具・〈C〉《親愛・哀れみ・軽べつなどの感情をこめて》人,者,やつ / 《the~》《話》(…の)流行《+in+名》
《所有・所属》…『の』,…のものである,…に属する・《材料・要素》…『でできた』,から成る・《部分》…『の』[『中の』] ・《数量・単位・種類を表す名詞に付いて》…の・《原因・動機》…『で』,のために(because of) ・《主格関係》…『の』,による,によって・《目的格関係》…『を』,の・《同格関係》…『という』・《関係・関連》…『についての』[『の』],の点で・《抽象名詞などと共に》…の[性質をもつ] ・《『It is』+『形』+『of』+『名』+『to』 doの形で,ofの後の名詞を意味上の主語として》・《分離》…『から』・《起原・出所》…『から』[『の』](out of) ・《『名』+『of』+『a』(『an』)+『名』の形で》…のような・《『名』+『of』+『mine』(『yours, his』など独立所有格)の形で》…の…・《時》(1)《副詞句を作って》…に《形容詞句を作って》…の・《時刻》《米》…前(to,《米》before)
《前述の名詞または文脈でそれと分かる名詞に付けて》『その』,あの,名の / 《唯一の事物に付けて》 / 《方角・自然現象に付けて》 / 《用具・楽器・特定の病気などに付けて》 / 《修飾吾[句]を伴う名詞に付けて》 / 《単数普通名詞に付けて》(1)《種族全体》…『というもの』 / 《複数名詞または集合名詞に付けて》 / 《単位》『…につき;…単位[で]』 / 《身体の一部に付けて,所有格に代わる》 / 《形容詞に付けて》 / 《固有名詞に付けて》 / 《強意用法に》『随一の』,典型的な / 《「the+比較級,the+比較級」の形で》『…すればするほどそれだけ』 / 《比較級の前に》(…につれて,のために)『それだけ』,ますます
(生物体内の)腺(せん)

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 唾液腺腫瘍：疫学、診断、評価、および病期分類salivary gland tumors epidemiology diagnosis evaluation and staging [show details]
…arising in the parotid, 40 to 45 percent of submandibular gland tumors, 70 to 90 percent of sublingual gland tumors, and 50 to 75 percent of minor salivary gland tumors are malignant. Histologically, the most …
2. 唾液腺腫瘍：限局性疾患の治療salivary gland tumors treatment of locoregional disease [show details]
…deep to the plane of the facial nerve, the facial nerve is preserved . For malignant tumors of the parotid gland, the extent of resection depends upon the histologic degree of differentiation, as well …
3. 頭頸部腫瘍の病理pathology of head and neck neoplasms [show details]
…cystic carcinoma (ACC) was previously considered to be the most common form of malignant minor salivary gland tumor . Many of these cases subsequently have been reclassified as polymorphous adenocarcinoma…
4. 唾液腺腫脹：評価および診断アプローチsalivary gland swelling evaluation and diagnostic approach [show details]
5. 頚部腫瘤の鑑別診断differential diagnosis of a neck mass [show details]
…submandibular gland than the parotid gland (50 versus 20 percent of tumors, respectively). Most benign salivary gland tumors are pleomorphic adenomas and present as asymptomatic enlarging masses. Pain, cranial nerve…

English Journal

Parapharyngeal space benign tumours: Our experience.

Cassoni A1, Terenzi V2, Della Monaca M1, Bartoli D1, Battisti A1, Rajabtork Zadeh O1, Valentini V1.Author information 1Maxillo-Facial Surg. Dept, Policlinico Umberto I, "Sapienza" University of Rome, Viale del Policlinico 155, 00100 Rome, Italy.2Maxillo-Facial Surg. Dept, Policlinico Umberto I, "Sapienza" University of Rome, Viale del Policlinico 155, 00100 Rome, Italy. Electronic address: v.terenzi@libero.it.AbstractOnly about 0.5% of all head and neck neoplasms occur in the parapharyngeal space (PPS) and approximately 80% of these tumours are benign lesions. Various surgical approaches some of which are associated with mandibulotomy to increase exposure have been described. This article describes our 16-years' experience in treating 60 PPS benign tumours with special focus on our surgical techniques intended to ensure adequate mass exposure and structure safety. On the basis of our experience we assert that mandibulotomy is currently not advocated in the surgical management of benign PPS tumours i.e. not even in very select cases. The transparotid approach is the treatment of choice for parotid gland lesions involving PPS and in cases of multinodular or uninodular pleomorphic adenoma relapse involving the PPS. The transcervical approach is suitable for the safe removal of even large PPS masses in most cases.
Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.J Craniomaxillofac Surg.2014 Mar;42(2):101-5. doi: 10.1016/j.jcms.2013.03.002. Epub 2013 May 17.
Only about 0.5% of all head and neck neoplasms occur in the parapharyngeal space (PPS) and approximately 80% of these tumours are benign lesions. Various surgical approaches some of which are associated with mandibulotomy to increase exposure have been described. This article describes our 16-years'
PMID 23684528

Histologic grade as prognostic indicator for mucoepidermoid carcinoma: A population-level analysis of 2400 patients.

Chen MM, Roman SA, Sosa JA, Judson BL.Author information Department of Surgery, Yale University School of Medicine, New Haven, Connecticut.AbstractBACKGROUND: Mucoepidermoid carcinoma (MEC) is an uncommon malignancy. To the best of our knowledge, this is the largest study investigating disease-specific survival (DSS) of parotid MEC and the first population-level study of the distribution of nodal metastases.
Head & neck.Head Neck.2014 Feb;36(2):158-63. doi: 10.1002/hed.23256. Epub 2013 Jun 14.
BACKGROUND: Mucoepidermoid carcinoma (MEC) is an uncommon malignancy. To the best of our knowledge, this is the largest study investigating disease-specific survival (DSS) of parotid MEC and the first population-level study of the distribution of nodal metastases.METHODS: Patients with MEC of the pa
PMID 23765800

Salivary gland tumors: A 20-year review of clinical diagnostic accuracy at a single center.

Lee WH1, Tseng TM2, Hsu HT3, Lee FP2, Hung SH3, Chen PY4.Author information 1Department of Otolaryngology, Head and Neck Surgery, Taipei Medical University-Shuang Ho Hospital, Taipei 110, Taiwan, R.O.C.2Department of Otolaryngology, Taipei Medical University Hospital, Taipei 110, Taiwan, R.O.C.3Department of Otolaryngology, Taipei Medical University Hospital, Taipei 110, Taiwan, R.O.C. ; Department of Otolaryngology, School of Medicine, Taipei Medical University, Taipei 235, Taiwan, R.O.C.4Department of Otolaryngology, Head and Neck Surgery, Taipei Medical University-Shuang Ho Hospital, Taipei 110, Taiwan, R.O.C. ; Department of Otolaryngology, School of Medicine, Taipei Medical University, Taipei 235, Taiwan, R.O.C.AbstractObtaining reliable pre-operative diagnosis is crucial in planning treatment for patients with salivary gland tumors. The purpose of this study was to evaluate the accuracy of pre-operative clinical diagnosis of salivary gland tumors managed at a single tertiary university hospital over a period of 20 years. A retrospective analysis of the period between 1992 and 2011 was carried out to review the cases of patients with salivary gland tumors. A total of 101 patients were enrolled and general data were described. Clinical diagnosis was compared with the final pathological diagnosis to reveal the clinical diagnostic accuracy. Of the parotid and submandibular gland tumors, 86 and 67% were benign, respectively. The clinical diagnostic accuracies for diagnosis of parotid tumors as benign or malignant were 100 and 57%, respectively. The clinical diagnostic accuracies for diagnosis of submandibular tumors as benign or malignant were 67%. Therefore, the overall clinical judgment of benign and malignant tumors in the submandibular gland is unreliable. The accuracy for a parotid tumor to be clinically interpreted as benign was 100%. While it is difficult to draw any conclusion for non-parotid gland tumors, surgical intervention should be recommended in patients with parotid tumors clinically suspected to be malignant, and all submandibular, sublingual and minor salivary gland tumors.
Oncology letters.Oncol Lett.2014 Feb;7(2):583-587. Epub 2013 Dec 10.
Obtaining reliable pre-operative diagnosis is crucial in planning treatment for patients with salivary gland tumors. The purpose of this study was to evaluate the accuracy of pre-operative clinical diagnosis of salivary gland tumors managed at a single tertiary university hospital over a period of 2
PMID 24396492